Neurology
1 drug is in development for Hearing Loss.
- Companies
- 1
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Hearing Loss pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| oto-413 | OTONOMY, INC. (OTIC) |
About this indication
Hearing Loss context
Neurology·MeSH: Hearing Loss (D034381)
Also known as: Hearing Impairment, Hypoacuses, Hypoacusis
Prevalence
5000.0 / 100K
Incidence
400.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Hearing Loss?
BioSniper tracks 1 drug in development for Hearing Loss across 1 company.
How many clinical trials target Hearing Loss?
There are 7 clinical trials targeting Hearing Loss tracked by BioSniper.
What is the prevalence of Hearing Loss?
The estimated prevalence of Hearing Loss is approximately 5000.0 per 100,000 population.